Login
Toggle navigation
Videos
Categories
Trending
Explore the Venture capital view of the investment process|Andrew Armour,Managing Partner,Chaac Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Founder and CIO at Catalina Advisors, LLC
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Deterring China's Aggression Against Taiwan|Matt Pottinger
00:10:00
Strategic Metals: Capitalizing on Yukon's Mining Potential
00:10:00
Exploring Rich Porphyry Copper-Gold Deposits in Ecuador: SolGold's Blueprint for Success
00:10:00
investing in early-stage companies and breakout companies|Oana Olteanu,Partner,SignalFire
00:10:00
Free Speech Insights with Nadine Strossen at S&C | William Nelson Cromwell - American attorney & Founder of Sullivan & Cromwell LLP
00:10:00
SNNLive interviewed Dr. Marco Chacon, President and CEO of Paragon BioServices, Inc., at the University of Maryland BioPark in Baltimore, MD.
00:10:00
Caverion's Operational Performance Strengthened Towards Year-End: CEO Comments on inderesTV | Jacob Götzsche - CEO of Caverion
00:10:00
Betting on a Comeback: Rob Sanderson’s Contrarian View on Snap’s Earnings Potential | Rob Sanderson - Managing Director, Loop Capital Markets
00:10:00
S2 Resources CEO Discusses New Opportunities and Projects in Victoria and WA
00:10:00
American West Metals' Strategic Growth and Milestone Achievements: Insights from Managing Director Dave O’Neill | Dave O'Neill, Managing Director , American West Metals Ltd.
00:10:00
AquaTech: Innovating Solutions for Global Water Scarcity
00:10:00
Attacq's Strategic Partnerships and Growth Initiatives: Pioneering New Horizons in Property Development|CEO, Attacq Limited